Understanding this pharmacokinetic profile helps patients and healthcare professionals make informed decisions about treatment changes, side effect management, and planning for surgery or pregnancy
A 31-gauge needle is tiny
Managing missed doses appropriately is important for maintaining therapeutic benefits while avoiding adverse effects from irregular dosing patterns
Tirzepatide: Prescribing and Treatment If a patient comes to me with hypertension (say, a blood pressure of 150/90), I may ask them about their salt and potassium intake, hydration, exercise, and nutrition
This variability may impact the overall consistency of the findings and the generalizability of our results
Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data
